MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a significant decrease in short interest during the month of July. As of July 15th, there was short interest totaling 13,638 shares, a decrease of 96.0% from the June 30th total of 341,209 shares. Based on an average trading volume of 96,017 shares, the short-interest ratio is presently 0.1 days.
MediPharm Labs Stock Performance
Shares of MEDIF opened at $0.06 on Friday. The company has a 50 day moving average of $0.05 and a two-hundred day moving average of $0.05. MediPharm Labs has a twelve month low of $0.04 and a twelve month high of $0.08.
About MediPharm Labs
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
See Also
- Five stocks we like better than MediPharm Labs
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
- AMD and Cerbras Create A New Blueprint For Hardware
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
